Atulya R. Agarwal

Intellectual Property

Partner
1841 Page Mill Road, Suite 150 Palo Alto, California 94304-1254
T: (650) 690-9559 agarwala@dicksteinshapiro.com

Biography

Atulya R. Agarwal is a seasoned attorney with more than 20 years of experience in the biotech and pharmaceutical industries. As a Silicon Valley-based partner in Dickstein Shapiro’s Intellectual Property Practice, he focuses on all aspects of IP strategy and portfolio management, including diligence, contracts, enforcement, and patent prosecution. Atulya leverages his 13 years of in-house legal department experience for major bio-pharmaceutical companies to advise his clients on how best to position their IP strategy and portfolios to maximize commercial value. Having frequently presented to management, executive committees, and boards of directors, he understands how to translate IP opportunities and challenges into business results. He also uses his deep understanding of in-house practice to taylor legal solutions that meet the business objectives of his clients.

AREAS OF CONCENTRATION

In addition to experience with all aspects of IP portfolio management, Atulya has developed significant experience with licensing, trademarks, copyrights, and trade secrets. He also has extensive knowledge about IP issues related to generics/biosimilars, life cycle management, and diagnostics/personalized medicine. In his prior in-house roles,  Atulya’s work resulted in significant improvement in IP protection across all types of portfolios, ranging from early stage projects all the way to commercial products, including the blockbuster products Tysabri® and Herceptin®.

BACKGROUND

Prior to joining Dickstein Shapiro, Atulya served as the chief intellectual property officer for Elan Pharmaceuticals, where he was a member of the leadership team. He oversaw all patent, copyright, trademark, IP litigation, and significant business development matters. Prior to Elan, Atulya spent more than a decade with the biotech firm Genentech, Inc., where he last served as head of patents for oncology. During his tenure at Genentech, he rose through the ranks, starting as a patent counsel and ultimately was responsible for all IP issues related to Genentech’s oncology portfolio, including life cycle management, patents, IP diligence, transactional matters, and litigation support. Atulya also worked as an associate for Pennie & Edmonds LLP and as a law clerk for Rae-Venter Law Group.

While in law school, he was an Emory Law Scholar and recipient of the High Tech Law Certificate. During his term at Boston University School of Medicine, he was a National Institutes of Health fellowship recipient.

PROFESSIONAL ACTIVITIES

Atulya is a member and active participant of numerous trade organizations, including the ABA, AIPLA, IPO, ACC, and SVAGC.

OUTSIDE THE FIRM

Atulya is married and has two children. In addition to enjoying time with his family and friends, he has a passion for life and also enjoys traveling and playing sports, especially tennis. Having grown up in Philadelphia, he also is a die-hard Philadelphia sports fan.

Full Biography

News and Views

View all News and Views

Bar Admissions

California
District of Columbia
U.S. Patent and Trademark Office